Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 31, 2015 6:51 PM ET

Healthcare Equipment and Supplies

Company Overview of VertiFlex Inc.

Company Overview

VertiFlex Inc., a medical device company, develops minimally invasive solutions for the treatment of lumbar spinal stenosis (LSS). It offers Superion Interspinous Spacer, a motion-preserving, indirect decompression spinal implant system for the treatment of moderate lumbar spinal stenosis. The company also provides Totalis Direct Decompression System specialized instruments to safely perform minimally invasive direct decompressions of the lumbar spine. VertiFlex Inc. was formerly known as DK Spine Technology Inc. The company was incorporated in 2004 and is based in San Clemente, California.

1351 Calle Avanzado

Suite 100

San Clemente, CA 92673

United States

Founded in 2004





Key Executives for VertiFlex Inc.

Chief Executive Officer, President and Director
Age: 68
Chief Financial Officer and Vice President
Vice President of Operations
Vice President of Clinical & Regulatory Affairs
Age: 63
Vice President of US Sales
Compensation as of Fiscal Year 2015.

VertiFlex Inc. Key Developments

VertiFlex Inc. Announces FDA PMA Approval for the Superion Interspinous Spacer

VertiFlex Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a PMA Approval Order for the company’s Superion Interspinous Spacer System, clearing the way for commercialization in the United States. Superion is indicated for moderate lumbar spinal stenosis, and is the least invasive motion preserving device in the category of interspinous spacers.

VertiFlex Inc. Presents at International Business Forum 14th Annual MedTech Investing Conference, May-06-2015 02:20 PM

VertiFlex Inc. Presents at International Business Forum 14th Annual MedTech Investing Conference, May-06-2015 02:20 PM. Venue: Loews Minneapolis Hotel, 601, 1st Ave North, Minneapolis, MN 55403, United States. Speakers: Earl R Fender, CEO.

VertiFlex Announces FDA Advisory Panel Support for the Superion® Interspinous Spacer

VertiFlex Inc. announced that the U.S. Food and Drug Administration’s (FDA) Orthopedic and Rehabilitation Devices Advisory Panel has voted strongly in support of the PreMarket Approval application for the company’s Superion® Interspinous Spacer System. The Panel voted that Superion demonstrated safety, effectiveness, and a favorable risk benefit profile based on the results from a 470 patient, multi-center, prospective and randomized controlled IDE trial.

Similar Private Companies By Industry

Company Name Region
Zap Lasers, LLC United States
Micro Health Systems, Inc. United States
Ranfac Corporation United States
AmbiMedInc United States
Reproductive Research Technologies, LP United States

Recent Private Companies Transactions

Private Placement
July 8, 2015
Private Placement
September 22, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VertiFlex Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at